Dermoscribe Seborrheic Dermatitis Cream
Product Images NDC 69683-202

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Dermoscribe Seborrheic Dermatitis (NDC 69683-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dermoscribe Pty Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Dermoscribe Seborrhea Dermatitis Cream Label)

DERMOGSCIRIBE's Seborrheic Dermatitis cream is a topical treatment for relieving the symptoms of Seborrheic Dermatitis. It contains ingredients such as Sulfur, Salicylic Acid, Hydrocortisone, and Aqueous Cream. The cream should only be used by individuals over the age of 12, and it is advised to apply it once or twice daily on the affected area as required while avoiding contact with the mouth, eyes, and anal skin. Users are also warned against swallowing the cream and advised to seek medical help before use if pregnant or breastfeeding. Store this product at room temperature. Detailed usage directions are available in the enclosed leaflet. KEEP OUT OF REACH OF CHILDREN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.